Forte Biosciences

FORTE BIOSCIENCES INC

Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).

Forte Biosciences Inc

Press Releases

Forte Biosciences to Host R&D Day December 3, 2024

Forte Biosciences, Inc. to Present at Upcoming Investor Meetings

Forte Biosciences, Inc. Announces Results and Provides Clinical Update

Forte Biosciences, Inc. Announces Results and Provides Update

Forte Biosciences Announces Positive Data in FB102 Celiac Disease Phase 1B Study

Forte Biosciences Announces Proposed Public Offering

Forte Biosciences Announces Pricing of $75 Million Public Offering

Forte Biosciences, Inc. Announces Presentation of FB102 Celiac Disease Trial at Tampere Celiac Disease Symposium

Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules

FBRX

Achieve Life Sciences, Inc. - Common Shares

Achieve Life Sciences

Alpha Cognition

Actuate Therapeutics, Inc. - Common stock

Actuate Therapeutics

Applied Therapeutics, Inc. - Common Stock

Applied Therapeutics

Assembly Biosciences, Inc. - Common Stock

Assembly Biosciences

Avalo Therapeutics

Cabaletta Bio

C4 Therapeutics

Compugen

Coherus Oncology

Corbus Pharmaceuticals Holdings, Inc. - Common Stock

Corbus Pharmaceuticals

Cardiff Oncology

Eledon Pharmaceuticals, Inc. - Common Stock

Eledon Pharmaceuticals

Elicio Therapeutics

Fate Therapeutics

Genfit

Genelux

Innate Pharma S.A. - American Depositary Shares

Innate Pharma

Seres Therapeutics

Nuvectis Pharma

Protalix BioTherapeutics, Inc. (DE) Common Stock

Protalix BioTherapeutics

Pyxis Oncology

Sangamo Therapeutics, Inc. - Common Stock

Sangamo Therapeutics

Protara Therapeutics, Inc. - Common Stock

Protara Therapeutics

Tonix Pharmaceuticals Holding Corp. - Common Stock

Comments

Forte Biosciences

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL